Close
USANA Executive Chairman Kevin Guest Encourages Self-Renewal with June's "Rebuild Your Life Month" Jun 3, 2024 07:37AM

SALT LAKE CITY, June 3, 2024 /PRNewswire/ -- For the month of June, Kevin Guest, executive chairman at USANA Health Sciences (NYSE: USNA), is emphasizing the significance of "Rebuild Your Life" month as an opportunity for individuals to take proactive steps toward healthier, more fulfilling lives.

Drawing upon life experiences and guiding principles in... (continue reading...)


FTAI Aviation Commences Cash Tender Offer for its 9.750% Senior Notes Due 2027 Jun 3, 2024 07:35AM

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ: FTAI), a Cayman Islands exempted company (the “Company” or “FTAI”) is announcing today that Fortress Transportation and Infrastructure Investors LLC (“FTAI LLC”), a wholly owned subsidiary of the Company, has commenced an offer (the “Tender Offer”) to purchase for cash up to $100,000,000 aggregate principal amount of its outstanding 9.750% Senior Notes due 2027 (the “2027... (continue reading...)


Bitfarms Provides May 2024 Production and Operations Update Jun 3, 2024 07:35AM

- Earned 156 BTC in May 2024 -- Secured additional hydropower in Paraguay with potential to add 6 EH/s in 2025 -- Increased installed hashrate to 9.5 EH/s with 7.5 EH/s operational -- Improved corporate energy efficiency to 27 w/TH, up 31% Y/Y & 13% M/M -- On track to deliver 21 EH/s and 21 w/TH in 2024 -  

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 8, 2024, to its... (continue reading...)


Neurocrine Biosciences Announces Publication of Primary CAHtalyst™ Pediatric Phase 3 Study Results of Crinecerfont for the Treatment of CAH in The New England Journal of Medicine Jun 3, 2024 07:35AM

-          CAHtalyst™ Pediatric Study Met Primary and Key Secondary Endpoints, with Crinecerfont Treatment Decreasing Androstenedione Levels and Enabling Glucocorticoid Dose Reduction While Maintaining Androstenedione Control     -          30% of Crinecerfont Participants Achieved a Physiologic Glucocorticoid Dose at Week 28 while Maintaining Androgen Control versus 0% of Placebo Participants     -          Favorable Trends in... (continue reading...)


Personas Provides Update Q1 Interim Financial Statement Jun 3, 2024 07:30AM

Toronto, Ontario--(Newsfile Corp. - June 3, 2024) - Personas Social Incorporated(TSXV: PRSN) (the "Company") announces that the 2024 Quarter 1 consolidated financial statements ("Financial Statements") and Management's Discussion and Analysis ("MD&A") for the quarter ending ended March 31st , 2024, have been filed with SEDAR.

The Company is proud to announce that the quarter ending ended March 31st, 2024, incurred a net loss of $2,359 compared to net income of $108,295... (continue reading...)


More Press Releases

View Older Stories

Jun 3, 2024 07:30AM Universal PropTech Inc. Announces Results of Annual General and Special Meeting of Shareholders
Jun 3, 2024 07:30AM Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2
Jun 3, 2024 07:30AM Redishred Capital Corp. Announces the Acquisition of Select Shred in Florida
Jun 3, 2024 07:30AM Rekor Systems to Present at Upcoming William Blair 44th Annual Growth Stock Conference
Jun 3, 2024 07:30AM ONCAP Announces Sale of Englobe’s Engineering Services Business
Jun 3, 2024 07:30AM Abcourt intersects 91.8 g/t Au over 0.5m at the Sleeping Giant Mine
Jun 3, 2024 07:30AM Relmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference
Jun 3, 2024 07:30AM Triple Hair Group Closes $4 Million Financing
Jun 3, 2024 07:30AM Neurocrine Biosciences Announces Publication of Primary CAHtalyst™ Adult Phase 3 Study Results of Crinecerfont for the Treatment of CAH in The New England Journal of Medicine
Jun 3, 2024 07:30AM AUXLY ANNOUNCES ANNUAL GENERAL MEETING OF SHAREHOLDERS
Jun 3, 2024 07:30AM Neurogene Announces NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for START Pilot Program
Jun 3, 2024 07:30AM Kelly Completes Acquisition of Motion Recruitment Partners, LLC
Jun 3, 2024 07:30AM Wesley Ramjeet to Join Lobe Sciences’ Board of Directors, Bringing Decades of Strategic Financial Expertise
Jun 3, 2024 07:30AM Acrisure Announces Proposed Notes Offering
Jun 3, 2024 07:30AM Gorman-Rupp Completes Debt Refinancing
Jun 3, 2024 07:30AM Health Recovery Solutions Appoints Jason Comer as CEO to Lead Next Phase of Growth
Jun 3, 2024 07:30AM DeFi Technologies' New Business Line, DeFi Alpha, a Specialized Arbitrage Trading Desk, Generates an Additional C$59.2 Million (US$43.4 Million) from Low-Risk Arbitrage Trades, Totaling Over C$11
Jun 3, 2024 07:30AM Spotline to Showcase Innovative Solutions at DIA 2024 in San Diego
Jun 3, 2024 07:30AM Acrisure Commences Tender Offer and Consent Solicitation
Jun 3, 2024 07:30AM TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
Jun 3, 2024 07:30AM Opthea To Present at Clinical Trials at the Summit Meeting
Jun 3, 2024 07:30AM Silver Storm Adds Second Drill Rig and Commences Phase 2 Drill Program at La Parrilla
Jun 3, 2024 07:30AM BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression
Jun 3, 2024 07:30AM Arrowhead Pharmaceuticals Reports Successful Topline Results for Plozasiran from the Pivotal Phase 3 PALISADE Study in Patients with Familial Chylomicronemia Syndrome
Jun 3, 2024 07:30AM Arcos Dorados to Participate in Upcoming Investor Event
Jun 3, 2024 07:30AM Devonian Appoints André P. Boulet to Chairman of the Board and Chief Operating Officer
Jun 3, 2024 07:30AM VitalHub Announces New Partnership with one of Toronto’s largest Child, Youth and Family Community Support Providers - Lumenus Community Services has licensed TREAT as their Integrated Electronic He
Jun 3, 2024 07:30AM Venus Concept Announces Approval for Venus Versa Pro in Canada
Jun 3, 2024 07:30AM Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290
Jun 3, 2024 07:30AM Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel
Jun 3, 2024 07:30AM Prairie Operating Co. Set to Join Russell 3000® Index
Jun 3, 2024 07:30AM VPG to Participate in the Sidoti June 2024 Small-Cap Investor Conference
Jun 3, 2024 07:30AM Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 3, 2024 07:30AM BrightSpring Completes $100 Million of Equity Grants to 20,000 Employees
Jun 3, 2024 07:30AM Ex-dividend date of Enefit Green is 10 June 2024
Jun 3, 2024 07:00AM Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year
Jun 3, 2024 07:00AM Eagle Plains Appoints New Chief Financial Officer, Issues Options
Jun 3, 2024 07:24AM APPROACHING INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that VinFast Auto Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - VFS
Jun 3, 2024 07:22AM GD's Dongguan unleashes trend of Chinese art toys culture in San Francisco
Jun 3, 2024 07:20AM G2 drills 46.5 m @ 1.1 g/t Au at NW OKO Discovery
Jun 3, 2024 07:00AM Meso Numismatics Updates Progress on Strategic Expansion Into the UAE With ReGen Dubai
Jun 3, 2024 07:17AM "Inspiration as Response: Eugen Popa and Contemporary Chinese Painting Documentation Exhibition" Opens at the China Cultural Center in Bucharest, Romania
Jun 3, 2024 07:15AM Bullion Hires Momentum PR Firm as Work Begins on Rivon Polymetallic Showing at Bodo Project
Jun 3, 2024 07:16AM Great Quest Appoints Dr. Andreas Rompel as President and VP Exploration
Jun 3, 2024 07:15AM Deeper Network Announces New Partnership Program Expanding Access to Revolutionary Internet Security Technology
Jun 3, 2024 07:15AM Procure Disaster Recovery Strategy ETF (NASDAQ:FIXT) Up 35% Since Launch
Jun 3, 2024 07:15AM Brennan Acquires Two Distribution Buildings in Denver
Jun 3, 2024 07:11AM Illumina appoints Everett Cunningham Chief Commercial Officer
Jun 3, 2024 07:10AM Mobilicom CEO Oren Elkayam to Participate in Fireside Chat at the “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era” Conference, presented by Maxim Group LLC, on
Jun 3, 2024 07:08AM Goliath Mobilizes For 15,000 Meter Drill Program To Test Surebet Feeder Source Plus Three New High-Grade Gold-Copper Targets Outcropping On Golddigger, Golden Triangle, B.C.
View Older Stories